
Veritas Aortic Solutions is a privately held medical device company committed to improving outcomes for patients with Aortic Disease. The company's flagship technology, the Veritas Transcatheter Valved Aortic Root Conduit (TVARC) is a single permanent implant that combines a bioprosthetic aortic valve, ascending aortic graft, and the company's proprietary Chameleon Eye coronary perfusion ports and is designed to seal-off the diseased or damaged part of the aorta and restore healthy blood flow to the coronaries and the rest of the body.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/01/26 | $12,000,000 | Seed |
Cedars-Sinai Medical Center | undisclosed |